Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US House Panel Advances Bill Allowing Medicare Coverage Of Eyeglasses, Hearing Aids, Dental Services

Executive Summary

Bills permitting Medicare coverage of eyeglasses, hearing aids, dental implants and the exams needed for prescriptions for these medical products were approved by the US House Energy and Commerce Committee on 17 October, and passed onto the full House for its consideration.

You may also be interested in...



US House Panel Approves Medicare Hearing, Dental And Vision Coverage; Senate Bill Introduced

Three bills that would supply vision, dental and hearing coverage benefits – including eyeglasses, dental implants and hearing aids – to Medicare recipients was passed by the US House Ways and Means Committee on 22 October. The same troika of bills was approved by the House Energy and Commerce Committee last week, and two Senate committees with health-care jurisdiction are considering similar legislation.

CMS Removes Some Stark Law ‘Bureaucratic Barriers’ In Final Rule

The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.

HHS OIG Keeps Eye Out For Device Firms Engaging In Speaker Program Fraud

The US health department's Office of Inspector General issued a special fraud alert under the Anti-Kickback Statute on health care speaker programs, to cut down on lucrative speaker deals and free meals to induce device purchases.

Topics

UsernamePublicRestriction

Register

OM006550

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel